Pregabalin Market Share

Statistics for the 2023 & 2024 Pregabalin market share, created by Mordor Intelligence™ Industry Reports. Pregabalin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Pregabalin Industry

The pregabalin market is moderately competitive with a number of established market players. The factors owing to the competition include approvals of generic drugs, rising partnerships among key market payers, and rising launch of different pregabalin formulations, among others. Some of the players operating in the market include Viatris Inc, Amneal Pharmaceuticals LLC, Zydus Group, Sciegen Pharmaceuticals Inc., Teva Pharmaceuticals, Rising Pharmaceuticals Inc., MSN Laboratories Ltd, and Cipla Limited.

Pregabalin Market Leaders

  1. Teva Pharmaceuticals

  2. Cipla Limited

  3. Medley Pharmaceuticals Limited

  4. Viatris Inc.

  5. Amneal Pharmaceuticals LLC

*Disclaimer: Major Players sorted in no particular order

Pregabalin Market Concentration

Pregabalin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)